Central adenosine A2A receptors:: an overview

被引:130
作者
Moreau, JL [1 ]
Huber, G [1 ]
机构
[1] F Hoffmann La Roche & Co Ltd, Preclin CNS Res, Div Pharma, PRPN, CH-4070 Basel, Switzerland
关键词
adenosine; A(2A) receptor; behavioural function; neuropsychiatric disorder;
D O I
10.1016/S0165-0173(99)00059-4
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Recent advances in molecular biology, biochemistry, cell biology and behavioral pharmacology together with the development of more selective ligands to the various adenosine receptors have increased our understanding of the functioning of central adenosine A(2A) receptors. The A(2A) receptor is one of four adenosine receptors found in the brain. Its expression is highest in striatum, nucleus accumbens and olfactory tubercles, although it also occurs in neurons and microglia in most other brain regions. The receptor has seven transmembrane domains and couples via Gs to adenyl cyclase stimulation. Antagonistic interactions between A(2A) receptors and dopamine D-2 receptors have been described, as stimulation of the A(2A) receptor leads to a reduction in the affinity of D-2 receptors for D-2 receptor agonists, The A(2A) receptor is thought to play a role in a number of physiological responses and pathological conditions. Indeed, A(2A) receptor antagonists may be useful for the treatment of acute and chronic neurodegenerative disorders such as cerebral ischemia or Parkinson's disease. A(2A) receptor agonists may treat certain types of seizures or sleep disorders. This review discusses the characteristics, distribution, pharmacochemical properties and regulation of central A(2A) receptors, as well as A(2A) receptor-mediated behavioural responses and their potential role in various neuropsychiatric disorders. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:65 / 82
页数:18
相关论文
共 198 条
  • [81] DORSAL PERIAQUEDUCTAL GRAY-INDUCED AVERSION AS A SIMULATION OF PANIC ANXIETY - ELEMENTS OF FACE AND PREDICTIVE-VALIDITY
    JENCK, F
    MOREAU, JL
    MARTIN, JR
    [J]. PSYCHIATRY RESEARCH, 1995, 57 (02) : 181 - 191
  • [82] Jiang QL, 1996, MOL PHARMACOL, V50, P512
  • [83] Distribution and postnatal ontogeny of adenosine A(2A) receptors in rat brain: Comparison with dopamine receptors
    Johansson, B
    Georgiev, V
    Fredholm, BB
    [J]. NEUROSCIENCE, 1997, 80 (04) : 1187 - 1207
  • [84] FURTHER CHARACTERIZATION OF THE BINDING OF THE ADENOSINE RECEPTOR AGONIST [H-3] CGS-21680 TO RAT-BRAIN USING AUTORADIOGRAPHY
    JOHANSSON, B
    FREDHOLM, BB
    [J]. NEUROPHARMACOLOGY, 1995, 34 (04) : 393 - 403
  • [85] Protection against hippocampal kainate excitotoxicity by intracerebral administration of an adenosine A2A receptor antagonist
    Jones, PA
    Smith, RA
    Stone, TW
    [J]. BRAIN RESEARCH, 1998, 800 (02) : 328 - 335
  • [86] Expression of adenosine A2a receptors gene in the olfactory bulb and spinal cord of rat and mouse
    Kaelin-Lang, A
    Lauterburg, T
    Burgunder, JM
    [J]. NEUROSCIENCE LETTERS, 1999, 261 (03) : 189 - 191
  • [87] Selective adenosine A(2A) receptor dopamine D-2 receptor interactions in animal models of schizophrenia
    Kafka, SH
    Corbett, R
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 295 (2-3) : 147 - 154
  • [88] Adenosine A2A receptors modify motor function in MPTP-treated common marmosets
    Kanda, T
    Tashiro, T
    Kuwana, Y
    Jenner, P
    [J]. NEUROREPORT, 1998, 9 (12) : 2857 - 2860
  • [89] KF17837 - A NOVEL SELECTIVE ADENOSINE A(2A) RECEPTOR ANTAGONIST WITH ANTICATALEPTIC ACTIVITY
    KANDA, T
    SHIOZAKI, S
    SHIMADA, J
    SUZUKI, F
    NAKAMURA, J
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 256 (03) : 263 - 268
  • [90] Adenosine A2A antagonist:: A novel antiparkinsonian agent that does not provoke dyskinesia in Parkinsonian monkeys
    Kanda, T
    Jackson, MJ
    Smith, LA
    Pearce, RKB
    Nakamura, J
    Kase, H
    Kuwana, Y
    Jenner, P
    [J]. ANNALS OF NEUROLOGY, 1998, 43 (04) : 507 - 513